Table 1. Characteristics of the Patients at Baseline.*.
| Characteristic | LY-CoV555 (N=309) |
Placebo (N=143) |
|---|---|---|
| Age | ||
| Median (range) — yr | 45 (18–86) | 46 (18–77) |
| 65 Yr or older — no. (%) | 33 (10.7) | 20 (14.0) |
| Female sex — no. (%) | 171 (55.3) | 78 (54.5) |
| Race or ethnic group — no./total no. (%)† | ||
| White | 269/305 (88.2) | 120/138 (87.0) |
| Hispanic or Latino | 135/309 (43.7) | 63/143 (44.1) |
| Black | 22/305 (7.2) | 7/138 (5.1) |
| Body-mass index‡ | ||
| Median | 29.4 | 29.1 |
| ≥30 to <40 — no./total no. (%) | 112/304 (36.8) | 56/139 (40.3) |
| ≥40 — no./total no. (%) | 24/304 (7.9) | 9/139 (6.5) |
| Risk factors for severe Covid-19 — no. (%)§ | 215 (69.6) | 95 (66.4) |
| Disease status — no. (%) | ||
| Mild | 232 (75.1) | 113 (79.0) |
| Moderate | 77 (24.9) | 30 (21.0) |
| Median no. of days since onset of symptoms | 4.0 | 4.0 |
| Mean viral load — Ct value¶ | 23.9 | 23.8 |
*
Covid-19 denotes coronavirus disease 2019.
†
Race or ethnic group was reported by the patients, who could choose more than one category.
‡
The body-mass index is the weight in kilograms divided by the square of the height in meters.
§
Risk factors were an age of 65 years or older, a body-mass index of 35 or more, or at least one coexisting illness in certain prespecified categories.
¶
Ct denotes the cycle threshold of the reverse-transcriptase–polymerase-chain-reaction assay.